A Method of Treating Diabetes Type 2 by Metformin and an Ultrarapid Acting Insulin
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 7 of these applications claim priority to application 61/087,943, filed Aug 11, 2008. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
| Patent | Title | Holder | Status | Expires | Time remaining | Confidence |
|---|---|---|---|---|---|---|
| US 8,119,593 | A Method of Treating Diabetes Type 2 by Metformin and an Ultrarapid Acting Insulin In force · High confidence | MannKind Corporation | In force | High confidence | ||
| US 9,943,571 | Use of Ultrarapid Acting Insulin In force · High confidence | MannKind Corporation | In force | High confidence | ||
| US 10,857,207 | Method of Treating Diabetes Type 2 by Administering Ultrarapid Acting Insulin In force · High confidence | MannKind Corporation | In force | High confidence | ||
| US 11,110,151 | Composition and Method for Reducing Hypoglycemia Events in Diabetes Treatment In force · High confidence | MannKind Corporation | In force | High confidence | ||
| US 11,998,591 | Method of Treating Diabetes Type 2 by Administering Ultrarapid Acting Insulin In force · High confidence | MannKind Corporation | In force | High confidence | ||
| US 8,623,817 | A Method of Treating Diabetes Type 2 by Administering Ultrarapid Acting Insulin In force · High confidence | MannKind Corporation | In force | High confidence | ||
| US 11,980,656 | A Method of Treating Hypoglycemia Events in Diabetes Treatment In force · Medium confidence | MannKind Corporation | In force | Medium confidence | ||
| Application 18/593,204 | Method of Treating Diabetes Type 2 by Administering Ultrarapid Acting Insulin Pending Not granted | MannKind Corporation | Pending | Not granted | ||
| Application 18/612,971 | Method of Treating Hypoglycemia Events in Diabetes Treatment Pending Not granted | MannKind Corporation | Pending | Not granted |
9 of 9 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
7 of these are in force and held by MannKind Corporation.
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.